Peripheral Artery Diseases (PAD)
Videos
VOYAGER: The role of rivaroxaban in PAD lower extremity revascularisation patients
Prof. Rupert Bauersachs about the outcomes of VOYAGER PAD at the CharingX congress 2020
Approval Code: PP-XAR-ALL-2035-1
anchor
VOYAGER PAD results and implications for clinical practice
Prof. S. Debus presents a vascular surgeon’s perspective
Approval Code: PP-XAR-ALL-1783-1
PAD patients in COVID times
Prof. R Bauersachs perspective on vascular care of during the COVID pandamic
Approval Code: PP-XAR-ALL-1859-1
anchor
VOYAGER PAD data presentation
Prof. M. Bonaca’s presentation the VOYAGER PAD trail results
Approval Code: PP-XAR-ALL-1867-1
anchor
VOYAGER PAD results and implications for clinical practice
Prof. R. Bauersachs presents a vascular physician’s perspective
Approval Code: PP-XAR-ALL-1785-1
New ESVM PAD guidelines discussed by Professor Jill Belch
PAD is a dangerous disorder that has a terminal event of death in many patients at five years
Approval Code: PP-XAR-ALL-1528-2
How to interpret the new ESVM PAD guidelines?
Professor Marianne Brodmann on the new ESVM PAD guidelines: “[With the] COMPASS study […] we show [for] the first time that we are able to save limbs.”
Approval Code: PP-XAR-ALL-1561-1
Images
Copyright © Bayer AG |
- G.MKT.GM.XA.08.2017.1727
Updated date 10/10/2022
La finalidad de este sitio web es proporcionar información al público
internacional fuera de los EE. UU. y el Reino Unido.
